S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Digital Therapeutics Market Projected to Reach $35 Billion by 2031

The global digital therapeutics market is set to more than triple in value over the next five years, climbing from $10.95 billion in 2026 to $35.37 billion by 2031. This rapid expansion, projected at a compound annual growth rate of 26.4%, reflects a fundamental shift toward clinically validated, AI-driven patient care.

Digital Therapeutics Market Projected to Reach $35 Billion by 2031
Photo: Bio & News

The industry is moving past simple wellness applications toward integrated platforms that offer personalized interventions and remote monitoring. Healthcare providers, employers, and pharmaceutical companies are increasingly adopting these tools to improve treatment adherence and clinical outcomes. Immersive technologies, including virtual and augmented reality, are expected to see the fastest growth as they become standard in pain management and neurological rehabilitation. Currently, North America maintains the largest market share, though Asia Pacific is emerging as the fastest-growing region due to significant government-led digital health initiatives and expanding mobile connectivity. B2B sales channels remain the primary driver, accounting for 73.6% of the market in 2025 as traditional healthcare systems integrate software-based therapeutics into routine clinical workflows.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!